Ajanta Pharma Ltd. News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Ajanta Pharma Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Ajanta Pharma Ltd.
Rating: 5
Author: Motilal Oswal

Keep track of all breaking news and updates on Ajanta Pharma Ltd. from all sources in a single place.

Load latest

Ajanta Pharma Ltd.

30 Jul 2024

2445.95

3.01%

Result

AJANTA PHARMA LTD. - 532331 - Outcome Of Board Meeting For Approving Unaudited Financial Results For …

BSE India

PFA outcome of Board Meeting

pdf

Ajanta Pharma Ltd.

30 Jul 2024

2445.95

3.01%

Branded generics drive earnings

Buy: Ajanta Pharma Ltd.

Target

Motilal Oswal

Ajanta Pharma (AJP) delivered better-than-expected 1QFY25 performance, led by a superior show in the branded Africa segment, lower raw material costs, and controlled other expenses.

Ajanta Pharma Ltd. has an average target of 2987.67 from 3 brokers.

Ajanta Pharma Ltd.

23 Jul 2024

2445.95

3.01%

Stock Market Live Updates 23 July 2024: Stock to buy today: Ajanta Pharma (2,291.05)

Business Line

Sensex, Nifty, Share Prices LIVE: Ajanta Pharma's stock, which depreciated after marking a record high of 2,531.95 in May, has now formed a good base at 2,200. The price action indicates good buying around these levels and the broader trend is bullish. Therefore, the likelihood of a rally in the forthcoming sessions is high. In the short term, Ajanta Pharma's price can rise to 2,500. But there might be a minor correction, possibly to 2,200, before the next upswing.

Ajanta Pharma Ltd. has an average target of 2987.67 from 3 brokers.

Stock to buy today: Ajanta Pharma (2,291.05)

Business Line | 23 Jul 2024

Ajanta Pharma Ltd.

18 Jul 2024

2445.95

3.01%

AGM

AJANTA PHARMA LTD. - 532331 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

Please find enclosed Voting Results pursuant to Regulation 44 of SEBI LODR Regulations and Scrutinizer''s Report.

pdf

Ajanta Pharma Ltd.

18 Jul 2024

2445.95

3.01%

AGM

AJANTA PHARMA LTD. - 532331 - Shareholder Meeting / Postal Ballot-Outcome of AGM

BSE India

Please find enclosed Proceedings of Annual General Meeting pursuant to Regulation 30 of SEBI LODR Regulations 2015.

pdf

Ajanta Pharma Ltd.

17 Jul 2024

2445.95

3.01%

Company Update

AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Cessation

BSE India

Please find enclosed Intimation for Cessation of Independent Directors on completion of their tenure.

pdf

Ajanta Pharma Ltd.

17 Jul 2024

2445.95

3.01%

Company Update

AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we are enclosing herewith the schedule of Earnings Conference Call to be held on 30th July 2024, post Board meeting.

pdf

Ajanta Pharma Ltd.

17 Jul 2024

2445.95

3.01%

Board Meeting

AJANTA PHARMA LTD. - 532331 - Board Meeting Intimation for Board Meeting Scheduled To Be Held …

BSE India

AJANTA PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2024 ,inter alia, to consider and approve unaudited consolidated and standalone financial results of the Company for the first quarter ended 30th June 2024.

pdf